Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adenosine deaminase and adenylate deaminase: comparative kinetic studies with transition state and ground state analogue inhibitors.

× No keyword cloud information.

14 in total

1. Anabolic pathway of 6-methoxypurine arabinoside in cells infected with varicella-zoster virus.

Authors: P de Miranda; T C Burnette; K K Biron; R L Miller; D R Averett; T A Krenitsky
Journal: Antimicrob Agents Chemother Date: 1991-10 Impact factor: 5.191

2. Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89.

Authors: M B Faletto; W H Miller; E P Garvey; M H St Clair; S M Daluge; S S Good
Journal: Antimicrob Agents Chemother Date: 1997-05 Impact factor: 5.191

3. The kinetics of slow-binding and slow, tight-binding inhibition: the effects of substrate depletion.

Authors: S G Waley
Journal: Biochem J Date: 1993-08-15 Impact factor: 3.857

4. Synthesis and Biochemical Testing of 3-(Carboxyphenylethyl)imidazo[2,1-f][1,2,4]triazines as Inhibitors of AMP Deaminase.

Authors: Stephen D Lindell; Simon Maechling; Richard L Sabina
Journal: ACS Med Chem Lett Date: 2010-06-18 Impact factor: 4.345

5. Adenine nucleotide pool perturbation is a metabolic trigger for AMP deaminase inhibitor-based herbicide toxicity.

Authors: Richard L Sabina; Anna-Lisa Paul; Robert J Ferl; Bernd Laber; Stephen D Lindell
Journal: Plant Physiol Date: 2007-02-16 Impact factor: 8.340

6. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.

Authors: A S Bagnara; M S Hershfield
Journal: Proc Natl Acad Sci U S A Date: 1982-04 Impact factor: 11.205

Adenosine deaminase and adenylate deaminase: comparative kinetic studies with transition state and ground state analogue inhibitors.

1. Anabolic pathway of 6-methoxypurine arabinoside in cells infected with varicella-zoster virus.

2. Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89.

3. The kinetics of slow-binding and slow, tight-binding inhibition: the effects of substrate depletion.

4. Synthesis and Biochemical Testing of 3-(Carboxyphenylethyl)imidazo[2,1-f][1,2,4]triazines as Inhibitors of AMP Deaminase.

5. Adenine nucleotide pool perturbation is a metabolic trigger for AMP deaminase inhibitor-based herbicide toxicity.

6. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.

7. The squalene-2,3-epoxide cyclase as a model for the development of new drugs.

8. Selection and amplification of heterologous genes encoding adenosine deaminase in mammalian cells.

9. The role of gene duplication in the evolution of purine nucleotide salvage pathways.

10. Metabolic disposition and pharmacokinetics of the antiviral agent 6-methoxypurine arabinoside in rats and monkeys.